Skip to content

Evaluation of Monthly Replacement Lenses in Habitual Soft Contact Lens Wearers Who Report Frequent Digital Devise Use

Evaluation of Monthly Replacement Lens Designs in Habitual Soft Contact Lens Wearers Who Report Frequent Digital Devise Use

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05166902
Enrollment
67
Registered
2021-12-22
Start date
2022-01-31
Completion date
2022-07-09
Last updated
2023-07-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ametropia

Brief summary

To evaluate the clinical performance of two monthly silicone hydrogel contact lenses in habitual wearers of frequent replacement (FRP) lenses when worn for 1-month.

Detailed description

This study is a prospective, bilateral eye, double-masked, randomized, 1-month cross-over, daily-wear design involving two different FRP lens types. Each lens type will be worn for approximately one month.

Interventions

Sponsors

Centre for Ocular Research & Education, Canada
CollaboratorOTHER
CooperVision, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

1. Is at least 18 years of age and no older than 35 years, and has full legal capacity to volunteer; 2. Has read and signed an information consent letter; 3. Is willing and able to follow instructions and maintain the appointment schedule; 4. Self-reports having a full eye examination in the previous two years; 5. Self-reports spending on most days at least 6 hours cumulative (not necessarily in one single stretch) using digital devices such as a computer, laptop, tablet, e-reader, smartphone; 6. Has healthy eyes with no health condition or medication that contra-indicate contact lens wear, in the opinion of the investigator; 7. Anticipates being able to wear the study lenses for at least 8 hours a day, 6 days a week; 8. Habitually wears soft frequent replacement contact lenses, for the past 3 months minimum (NOTE: The habitual contact lens brand was restricted such that no more than one third were to be Biofinity Energys brand (or their equivalent private label brand name) and no more than one third were to be Alcon brand); 9. Has refractive astigmatism no higher than -0.75DC in each eye; 10. Can be fit and achieve binocular distance vision of at least 20/30 Snellen (Available lens parameters are sphere +6.00 to -6.00D, 0.25D steps).

Exclusion criteria

1. Is participating in any concurrent clinical or research study; 2. Has any known active ocular disease and/or infection that contraindicates contact lens wear; 3. Has a systemic or ocular condition that in the opinion of the investigator may affect a study outcome variable; 4. Is using any systemic or topical medications that in the opinion of the investigator may affect contact lens wear or a study outcome variable; 5. Has known sensitivity to the diagnostic sodium fluorescein used in the study; 6. Self-reports as pregnant, lactating or planning a pregnancy at the time of enrolment; 7. Has undergone refractive error surgery or intraocular surgery.

Design outcomes

Primary

MeasureTime frameDescription
Subjective Ratings on Lens Handling on RemovalDay 27Subjective ratings on lens handling on removal will be measured on a scale of 0-10, 0.5 steps (10= Very Easy, 0= Very Difficult)

Countries

Canada, United States

Participant flow

Pre-assignment details

Sixty-seven participants were screened with no screen failures. One participant discontinued and the remaining 66 all completed the study. All the participants who completed the study were included in the analysis. (Analysis population n=66)

Participants by arm

ArmCount
Analysis Population
Sixty-six participants completed the study, and demographic data include all participants who completed the study.
66
Total66

Withdrawals & dropouts

PeriodReasonFG000FG001
First InterventionLost to Follow-up01

Baseline characteristics

CharacteristicAnalysis Population
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
66 Participants
Age, Continuous27.8 Years
STANDARD_DEVIATION 4.4
Race and Ethnicity Not Collected— Participants
Sex: Female, Male
Female
51 Participants
Sex: Female, Male
Male
15 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 660 / 66
other
Total, other adverse events
4 / 662 / 66
serious
Total, serious adverse events
0 / 660 / 66

Outcome results

Primary

Subjective Ratings on Lens Handling on Removal

Subjective ratings on lens handling on removal will be measured on a scale of 0-10, 0.5 steps (10= Very Easy, 0= Very Difficult)

Time frame: Day 27

Population: Participants

ArmMeasureValue (MEAN)Dispersion
Lens ASubjective Ratings on Lens Handling on Removal8.3 Units on scaleStandard Deviation 1.8
Lens BSubjective Ratings on Lens Handling on Removal8.8 Units on scaleStandard Deviation 1.2

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026